Assessment of the Potential for Displacement Interactions with Sugammadex: A Pharmacokinetic-Pharmacodynamic Modelling Approach

Author： Zwiers Alex

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.2, 2011-02, pp. : 101-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic-Pharmacodynamic Modelling of Recombinant Human Erythropoietin in Athletes: A Population Approach

By Gaudard A.G.

Clinical Drug Investigation, Vol. 23, Iss. 3, 2003-01 ,pp. : 167-179

Adis International

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B. Jusko William J.

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Current and future directions of pharmacokinetic and pharmacokinetic–pharmacodynamic modelling and simulation: Population Approach Group in Europe 19th annual meeting

By Kloft Charlotte Poggesi Italo

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1599-1604

Informa Healthcare

Access to resources Recommend Favorite